Navigation Links
Extended Therapy for Blood Clots

An oral drug given after a standard six-month treatment could help prevent future blood clots in patients, according to new research.//

Venous thromboembolism (VTE) affects approximately 2 million Americans each year. VTE includes deep vein thrombosis (blood clots common in the thigh and back) and pulmonary embolism (blood clots common in the lung). Despite progress in diagnosis and treatment, VTE is still associated with high morbidity and mortality. While previous studies have shown a risk of recurrence after six months, treatment is often stopped after six months because of the risk of bleeding. A new study examines the use of the oral drug ximelagatran or placebo as a treatment after the six-month standard treatment.

The study included 1,233 patients with VTE who had six months of anticoagulant therapy. Half of the patients were then given the drug ximelagatran and the other half was given a placebo for 18 months. Researchers then analyzed how the patients did on the drug compared to those on the placebo.

Researchers report only 12 patients on ximelagatran had a recurrent problem compared with 71 patients on the placebo. They found six patients on the drug died during the 18 months compared with seven patients who died in the placebo group. However, 134 patients on ximelagatran experienced bleeding compared to 111 patients on the placebo. Still, study authors point out that the risk of major hemorrhage was low. Researchers say those patients on ximelagatran had high levels of alanine aminotransferase which is an enzyme present in the liver and heart cells. The levels of this enzyme in patients on the drug were more than three-times the normal level and cause a concern for more research on this treatment, according to study authors.

In conclusion, researchers say the drug ximelagatran is superior to placebo for an extended treatment for VTE. However, they say more research is needed to understand why patients on the tre atment had high levels of a certain enzyme.
'"/>




Related medicine news :

1. Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac
2. Drug Courts In Europe Extended For Three More Years
3. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
4. Tenure of Mental Health CommissionExtended
5. Pharmaceutical Benefits Scheme Extended for 2 Novel Breast Cancer Drugs
6. Babies with Cleft Conditions, Pierre Robin Sequence May Need Extended Treatment for Poor Feeding Skills
7. Survival of Mice With Human Breast Cancer Extended by Monoclonal Antibodies
8. Cancer Doctors Okays Controversial Prostate Therapy
9. Consensus on "Combination Therapy" for Breast Cancer
10. Gene Therapy shows promise in treating Hemophilia
11. "Make AIDS Therapy affordable" - Physicians demand
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... May 05, 2016 , ... Augusta Public Schools has teamed ... This partnership will enable school health offices to streamline and bolster care for district ... just east of Wichita. Augusta public schools serve 2,300 students among its six schools. ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... announce that Dr. Julie Lombardo, PT, DPT, MA, OCS, WCS, has been selected ... WPTA Private Practice Award. The WPTA Private Practice Award is awarded annually to ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... patented products, announces the Everlasting Glove, a sports invention that aids in the ... Sporting Goods Manufacturing industry is worth $9 billion," says Scott Cooper, CEO and ...
(Date:5/4/2016)... ... May 04, 2016 , ... Connor Sport Court ... for the 2016 NCAA Men’s National Collegiate Volleyball Championship. , Sport ... championship to be held May 5-7 at Pennsylvania State University’s Rec Hall in ...
(Date:5/4/2016)... ... May 04, 2016 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... the esteemed Quaker Ridge Golf Club in Scarsdale, New York on May 23, ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... India , May 3, 2016 ... 2016 Research Report provides a basic overview of ... technology, post which the surgical mesh report explores ... market. Complete report on Surgical Mesh ... profiles and 98 tables and figures is available ...
(Date:5/2/2016)... May 2, 2016 Kalorama Information noted the ... Records) market in a recent white paper.  The healthcare ... physician usage, a growing market are among the top ... Kalorama,s report EMR 2016: The Market for ... seventh complete study of the EMR industry, and the ...
(Date:5/2/2016)... YORK , May 2, 2016  Deerfield ... B financing of Graybug Vision, Inc. Graybug Vision ... developing therapies that may transform care for ocular ... glaucoma.  Graybug Vision,s technology was first developed at ... into a startup venture. Graybug ...
Breaking Medicine Technology: